Unione Europea - italiano - EMA (European Medicines Agency)

acino ag - clopidogrel - peripheral vascular diseases; acute coronary syndrome; myocardial infarction; stroke - agenti antitrombotici - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , , , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease, non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa), st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy, patients suffering from acute coronary syndrome. , ,.

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

acino pharma ag - amoxicillinum anhydricum, acido clavulanicum - polvere per sospensione orale - amoxicillinum anhydricum 400 mg ut amoxicillinum trihydricum, acidum clavulanicum 57 mg ut kalii clavulanas, silica colloidalis anhydrica, xanthani gummi, crospovidonum, carmellosum natricum, aspartamum 16.64 mg, aromatica (erdbeer) cum alcohol benzylicus et propylenglycolum, ad pulverem corresp., suspensio reconstituta 5 ml corresp. natrium max. 7.3 mg. - malattie infettive - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

acino pharma ag - levofloxacinum - compresse rivestite con film - levofloxacinum 250 mg ut levofloxacinum hemihydricum, natrii stearylis fumaras, crospovidonum, silica colloidalis anhydrica, copovidonum, cellulosum microcristallinum, Überzug: lactosum monohydricum 3.84 mg, hypromellosum, triacetinum, e 171, e 172 (rubrum), e 172 (flavum), pro compresso obducto corresp. natrium 1.8 mg. - malattie infettive - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

acino pharma ag - levofloxacinum - compresse rivestite con film - levofloxacinum 500 mg ut levofloxacinum hemihydricum, natrii stearylis fumaras, crospovidonum, silica colloidalis anhydrica, copovidonum, cellulosum microcristallinum, Überzug: lactosum monohydricum 7.68 mg, hypromellosum, triacetinum, e 171, e 172 (rubrum), e 172 (flavum), pro compresso obducto corresp. natrium 3.7 mg. - malattie infettive - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

acino pharma ag - pantoprazolum - le compresse gastroresistenti di - pantoprazolum 20.00 mg ut pantoprazolum natricum sesquihydricum, natrii carbonas, mannitolum, crospovidonum, povidonum k 90, calcii stearas, Überzug: hypromellosum, povidonum k 25, e 171, e 172 (flavum), propylenglycolum, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, triethylis citras, drucktinte: lacca, e 172 (rubrum), e 172 (nigrum), e 172 (flavum), ammoniae solutio concentrata, pro compresso obducto corresp. natrium 3.38 mg. - inibitori della pompa protonica - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

acino pharma ag - pantoprazolum - le compresse gastroresistenti di - pantoprazolum 40.00 mg ut pantoprazolum natricum sesquihydricum, natrii carbonas, mannitolum, crospovidonum, povidonum k 90, calcii stearas, Überzug: hypromellosum, povidonum k 25, e 171, e 172 (flavum), propylenglycolum, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, triethylis citras, drucktinte: lacca, e 172 (rubrum), e 172 (nigrum), e 172 (flavum), ammoniae solutio concentrata, pro compresso obducto corresp. natrium 6.75 mg. - inibitori della pompa protonica - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

acino pharma ag - amoxicillinum anhydricum, acido clavulanicum - polvere per sospensione orale - amoxicillinum anhydricum 125 mg ut amoxicillinum trihydricum, acidum clavulanicum 31.25 mg ut kalii clavulanas, silica colloidalis anhydrica, xanthani gummi, crospovidonum, carmellosum natricum, aromatica (erdbeer) cum alcohol benzylicus et propylenglycolum, aspartamum 8.32 mg, ad suspensionem corresp. suspensio reconstituta 5 ml corresp. natrium max. 2.35 mg. - malattie infettive - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

acino pharma ag - metoprololi succinas - retardtabletten - metoprololi tartras 25 mg corresp. metoprololi succinas 23.75 mg, sacchari sphaerae corresp. saccharum 1.84 mg et maydis amylum, macrogolum 6000, polyacrylatis dispersio 30 per centum, talcum, povidonum, cellulosum microcristallinum, magnesii stearas, silica colloidalis anhydrica, Überzug: hypromellosum, talcum, macrogolum 6000, e 171, pro compresso obducto. - beta-dei recettori adrenergici - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

acino pharma ag - metoprololi succinas - retardtabletten - metoprololi tartras 50 mg corresp. metoprololi succinas 47.5 mg, sacchari sphaerae corresp. saccharum 3.68 mg et maydis amylum, macrogolum 6000, polyacrylatis dispersio 30 per centum, talcum, povidonum, cellulosum microcristallinum, magnesii stearas, silica colloidalis anhydrica, Überzug: hypromellosum, talcum, macrogolum 6000, e 171, pro compresso obducto. - beta-dei recettori adrenergici - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

acino pharma ag - metoprololi succinas - retardtabletten - metoprololi tartras 100 mg corresp. metoprololi succinas 95 mg, sacchari sphaerae corresp. saccharum 7.36 mg et maydis amylum, macrogolum 6000, polyacrylatis dispersio 30 per centum, talcum, povidonum, cellulosum microcristallinum, magnesii stearas, silica colloidalis anhydrica, Überzug: hypromellosum, talcum, macrogolum 6000, e 171, pro compresso obducto. - beta-dei recettori adrenergici - synthetika